Syndrome News and Research

RSS

Vaccination and BA.1 breakthrough infection induce neutralizing antibodies less efficient against BA.4 and BA.5 Omicron variants

A new study aimed to describe the appearance of the Omicron variants in Israel, from March to June 2022, as well as the neutralizing antibody response against the primary Omicron subvariants.

2 Aug 2022

How can researchers profile post-COVID syndromes among distinct SARS-CoV-2 variants?

In a new study, researchers profiled post-coronavirus disease (COVID) syndrome (PCS) throughout various SARS-CoV-2 variants.

2 Aug 2022

Adults aged ≥50 years boosted with SARS-CoV-2 mRNA vaccines less likely to experience adverse reactions after second booster than during initial booster

A new study monitored the safety of the second booster dose of SARS-CoV-2 messenger ribonucleic acid vaccination among those ≥50 Years.

2 Aug 2022

Lyme disease remains a growing public health concern in the United States, says FAIR Health study

Lyme disease has experienced notable growth in the United States over the past 15 years and, as a result, has become an illness of increasing national concern. From 2007 to 2021, private insurance claim lines with Lyme disease diagnoses rose 357 percent in rural areas and 65 percent in urban areas. These and other findings on this tick-borne, bacterial illness were captured in an infographic just released by FAIR Health. The national, independent organization used its database of over 36 billion privately billed healthcare claims to conduct its 15-year analysis of Lyme disease; this analysis builds upon a previous FAIR Health infographic that studied 10 years of Lyme disease data.

2 Aug 2022

Study explores differential antibody-mediated effector functions evoked by two mRNA-based COVID-19 vaccines

Researchers evaluated the differential humoral immune response to two COVID-19 vaccines - messenger ribonucleic acid (mRNA)-1273 and BNT162b2.

2 Aug 2022

Plasma myosin light chain 9 levels may be better predictor of COVID-19 severity than blood biomarkers

In a new study, researchers found elevated plasma levels of myosin light chain 9 (Myl9) in COVID-19 patients with a fatal disease.

2 Aug 2022

Long-term symptoms 23 months after SARS-CoV-2 infection

Scientists analyzed COVID-19 symptoms lasting 23 months after the infection.

2 Aug 2022

How does Omicron BA.1 infection impact the risk of reinfection with BA.5?

Researchers found prior exposure to SARS-CoV-2 Omicron sub-variants BA.1/BA.2 reduced the risk of breakthrough infection by its sub-variant BA.5.

2 Aug 2022

What are the hidden sources of SARS-CoV-2 evolution?

A recent article published in Transplant Infectious Disease examined case reports on SARS-CoV-2 evolution in immunosuppressed cohorts.

2 Aug 2022

What is the efficacy of COVID-19 BNT162b2 and mRNA-1273 booster vaccinations?

In a new study, scientists compared the effectiveness of the SARS-CoV-2 BNT162b2 and mRNA-1273 vaccines booster doses in England.

2 Aug 2022

Study suggests peimine may be a potent inhibitor of SARS-CoV-2 variant infection

A recent study published in the Journal of Food Biochemistry discovered that peimine from Fritillaria might be a possible SARS-CoV-2 variant infection inhibitor.

2 Aug 2022

mRNA vaccines induce faster antibody response against infectious diseases

A new study describes that mRNA vaccines induce antigen-specific antibody response within a very short period of time after immunization.

2 Aug 2022

The efficacy of honokiol in inhibiting SARS-CoV-2 replication in cell culture

Researchers evaluated the efficacy of honokiol in inhibiting SARS-CoV-2 replication in cell cultures.

2 Aug 2022

The impact of respiratory droplet volume and their evaporation kinetics on environmental stability of respiratory viruses

Researchers measured the impact of initial respiratory droplet volume and relative humidity on the environmental stability of respiratory viruses, including influenza A and SARS-CoV-2.

2 Aug 2022

Syndrome News and Research

Vaccination and BA.1 breakthrough infection induce neutralizing antibodies less efficient against BA.4 and BA.5 Omicron variants

How can researchers profile post-COVID syndromes among distinct SARS-CoV-2 variants?

Adults aged ≥50 years boosted with SARS-CoV-2 mRNA vaccines less likely to experience adverse reactions after second booster than during initial booster

Lyme disease remains a growing public health concern in the United States, says FAIR Health study

Study explores differential antibody-mediated effector functions evoked by two mRNA-based COVID-19 vaccines

Plasma myosin light chain 9 levels may be better predictor of COVID-19 severity than blood biomarkers

Long-term symptoms 23 months after SARS-CoV-2 infection

How does Omicron BA.1 infection impact the risk of reinfection with BA.5?

What are the hidden sources of SARS-CoV-2 evolution?

What is the efficacy of COVID-19 BNT162b2 and mRNA-1273 booster vaccinations?

Study suggests peimine may be a potent inhibitor of SARS-CoV-2 variant infection

mRNA vaccines induce faster antibody response against infectious diseases

The efficacy of honokiol in inhibiting SARS-CoV-2 replication in cell culture

The impact of respiratory droplet volume and their evaporation kinetics on environmental stability of respiratory viruses

Carbon monoxide foam in the fight against inflammation

Reduced severity of COVID-19 in pregnant women during the Omicron wave

Study suggests possible benefit from melatonin in COVID-19

Nasal epithelium of children inhibits infection and replication of ancestral SARS-CoV-2

How does COVID-19 affect sexual and bladder functions in men?

Study finds negative impact of COVID-19 pandemic on mental health status in low and middle income countries

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News